Loading... Please wait... Loading... Please wait...
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $42.02 | $2.70 B | -7.55 | 383 | $26.82 M | ||
| Alector, Inc. | $4.41 | $420.24 M | -3.14 | 244 | $97.06 M | ||
| Alnylam Pharmaceuticals, Inc. | $248.68 | $19.33 B | -57.65 | 2100 | $1.83 B | ||
| Apellis Pharmaceuticals, Inc. | $35.41 | $4.90 B | -11.77 | 702 | $396.59 M | ||
| Ascendis Pharma A/S | $134.18 | $7.77 B | -14.19 | 879 | $266.72 M | ||
| BeiGene, Ltd. | $147.98 | $17.07 B | -20.76 | 10000 | $2.46 B | ||
| BioMarin Pharmaceutical Inc. | $80.98 | $15.32 B | 76.12 | 3401 | $2.42 B | ||
| Blueprint Medicines Corporation | $109.03 | $6.47 B | -21.48 | 645 | $249.38 M | ||
| Cerevel Therapeutics Holdings, Inc. | $40.30 | $7.29 B | -14.66 | 355 | $0 | ||
| Cytokinetics, Incorporated | $54.40 | $6.05 B | -9.78 | 423 | $7.53 M | ||
| DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 | ||
| Edgewise Therapeutics, Inc. | $18.28 | $1.65 B | -11.47 | 92 | $0 | ||
| Exelixis, Inc. | $21.96 | $6.37 B | 33.66 | 1310 | $1.83 B | ||
| Inhibrx, Inc. | $13.44 | $241.02 M | -1.44 | 166 | $1.80 M | ||
| Insmed Incorporated | $62.00 | $9.17 B | -10.87 | 912 | $305.21 M | ||
| Legend Biotech Corporation | $45.91 | $8.31 B | -17.66 | 2000 | $285.14 M | ||
| Larimar Therapeutics, Inc. | $7.63 | $611.84 M | -9.99 | 42 | $0 | ||
| Protagonist Therapeutics, Inc. | $34.50 | $2.04 B | 13.7 | 124 | $60.00 M | ||
| Ultragenyx Pharmaceutical Inc. | $40.21 | $3.44 B | -5.21 | 1276 | $434.25 M | ||
| Seagen Inc. | $228.74 | $43.15 B | -57.19 | 3256 | $1.96 B | ||
| Viridian Therapeutics, Inc. | $12.25 | $776.72 M | -2.71 | 94 | $314,000 |
